Time to consider alternatives: europepmc.org

Of course I love that picture as well... Jürgen Floege😉

KDIGO GEMs: Glomerular Diseases Join me at #kdigogdgems - A virtual event covering ANCA vasculitis, complement-mediated kidney disease, IgA nephropathy and lupus nephritis

KDIGO is holding its inaugural Guideline Education Meetings (GEMs) focusing on glomerular diseases. This virtual program, available in multiple time zones, covers Lupus Nephritis, ANCA-Vasculitis, IgA Nephropathy, and Complement-Mediated Kidney Disease.
More info + registration at: www.gems-gd.org.

Look forward to this article in Clinical Kidney Journal:
The role of Obinutuzumab in rituximab-refractory membranous nephropathy and minimal change disease. Obi becomes more and more attractive..

Merry Christmas everybody! Let's try to make 2025 a wonderful year despite all the news.....

Updates in IgA Nepropathy - YouTube Learn the latest advancements in the understanding and management of IgA Nephropathy (IgAN) with two expert-led videos with Professors Brad Rovin, MD (United...

Wanna hear the latest about KDIGO and IgA nephropathy? Watch this...:
eur02.safelinks.protection.outlook.com?url=https%3A...

KDIGO GEMs: Glomerular Diseases Join me at #kdigogdgems - A virtual event covering ANCA vasculitis, complement-mediated kidney disease, IgA nephropathy and lupus nephritis

Don't miss the first KDIGO GEMs (Guideline Education Meetings), a new program offering virtual education on the latest KDIGO Guidelines and evidence-based updates on Jan 13 and 14, 2025:
eur02.safelinks.protection.outlook.com?url=https%3A...

Nice data on how to treat IgA nephropathy from Germany

Look forward to this article to appear in CKJ in the next days:
HOW TO IMPROVE THE ENVIRONMENTAL IMPACT IN HEMODIALYSIS: SMALL ACTIONS, BIG CHANGES
We can not go on like we used to.....